# Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

> **NCT01111955** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 62 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** Placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01111955
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01111955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01111955, "Safety Study of BMS-823778 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01111955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*